Structural basis of arrestin-3 activation and signaling

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Chen, Qiuyan ^a   Perry, Nicole A ^a   Vishnivetskiy, Sergey A ^a   Berndt, Sandra ^a   Gilbert, Nathaniel C ^a,e   Zhuo, Ya ^b   Singh, Prashant K ^a   Tholen, Jonas ^c   Ohi, Melanie D ^a   Gurevich, Eugenia V ^a   Brautigam, Chad A ^d   Klug, Candice S ^b   Gurevich, Vsevolod V ^a   Iverson, T M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF APPLIED SCIENCES EMDEN LEER   (Germany)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARRESTIN 3; PHOSPHATE; PHYTIC ACID; RETINA S ANTIGEN; UNCLASSIFIED DRUG; ARRESTIN3; MITOGEN ACTIVATED PROTEIN KINASE 10; RECOMBINANT PROTEIN;

CHEMICAL BINDING; PHOSPHATE; PHYSIOLOGY; PROTEIN;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; COS-7 CELL LINE; HEK293 CELL LINE; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN STRUCTURE; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SURFACE PROPERTY; AMINO ACID SEQUENCE; ANIMAL; BOVINE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MOLECULAR MODEL; PROTEIN QUATERNARY STRUCTURE; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; ARRESTINS; BINDING SITES; CATTLE; CRYSTALLOGRAPHY, X-RAY; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 10; MODELS, MOLECULAR; PHYTIC ACID; PROTEIN CONFORMATION; PROTEIN STRUCTURE, QUATERNARY; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 85033606940     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-01218-8     Document Type: Article

References (68)

1. Wilden, U., Hall, S. W. & Kuhn, H. Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments. Proc. Natl Acad. Sci. USA 83, 1174-1178 (1986).
2. DeWire, S. M., Ahn, S., Lefkowitz, R. J. & Shenoy, S. K. Beta-Arrestins and cell signaling. Annu. Rev. Physiol. 69, 483-510 (2007).
3. Xiao, K. et al. Functional specialization of beta-Arrestin interactions revealed by proteomic analysis. Proc. Natl Acad. Sci. USA 104, 12011-12016 (2007).
4. Han, M., Gurevich, V. V., Vishnivetskiy, S. A., Sigler, P. B. & Schubert, C. Crystal structure of beta-Arrestin at 1.9 A: possible mechanism of receptor binding and membrane translocation. Strucutre 9, 869-880 (2001).
5. Gurevich, V. V. & Benovic, J. L. Visual arrestin interaction with rhodopsin. Sequential multisite binding ensures strict selectivity toward light-Activated phosphorylated rhodopsin. J. Biol. Chem. 268, 11628-11638 (1993).
6. Zhan, X., Gimenez, L. E., Gurevich, V. V. & Spiller, B. W. Crystal structure of arrestin-3 reveals the basis of the difference in receptor binding between two non-visual subtypes. J. Mol. Biol. 406, 467-478 (2011).
7. Hirsch, J. A., Schubert, C., Gurevich, V. V. & Sigler, P. B. The 2.8 A crystal structure of visual arrestin: A model for arrestin's regulation. Cell 97, 257-269 (1999).
8. Sutton, R. B. et al. Crystal structure of cone arrestin at 2.3 A: evolution of receptor specificity. J. Mol. Biol. 354, 1069-1080 (2005).
9. Gurevich, V. V. & Gurevich, E. V. The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. Pharmacol. Ther. 110, 465-502 (2006).
10. Kim, Y. J. et al. Crystal structure of pre-Activated arrestin p44. Nature 497, 142-146 (2013).
11. Shukla, A. K. et al. Structure of active beta-Arrestin-1 bound to a G-protein-coupled receptor phosphopeptide. Nature 497, 137-141 (2013).
12. Granzin, J., Stadler, A., Cousin, A., Schlesinger, R. & Batra-Safferling, R. Structural evidence for the role of polar core residue Arg175 in arrestin activation. Sci. Rep. 5, 15808 (2015).
13. Kang, Y. et al. Crystal structure of rhodopsin bound to arrestin determined by femtosecond X-ray laser. Nature 523, 561-567 (2015).
14. Breitman, M. et al. Silent scaffolds: inhibition OF c-Jun N-Terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant. J. Biol. Chem. 287, 19653-19664 (2012).
15. McDonald, P. H. et al. Beta-Arrestin 2: A receptor-regulated MAPK scaffold for the activation of JNK3. Science 290, 1574-1577 (2000).
16. Miller, W. E. & Lefkowitz, R. J. Expanding roles for beta-Arrestins as scaffolds and adapters in GPCR signaling and trafficking. Curr. Opin. Cell. Biol. 13, 139-145 (2001).
17. Zhan, X., Kaoud, T. S., Kook, S., Dalby, K. N. & Gurevich, V. V. JNK3 enzyme binding to arrestin-3 differentially affects the recruitment of upstream mitogen-Activated protein (MAP) kinase kinases. J. Biol. Chem. 288, 28535-28547 (2013).
18. Zhan, X., Kook, S., Gurevich, E. V. & Gurevich, V. V. Arrestin-dependent activation of JNK family kinases. Handb. Exp. Pharmacol. 219, 259-280 (2014).
19. Palczewski, K., Pulvermuller, A., Buczylko, J. & Hofmann, K. P. Phosphorylated rhodopsin and heparin induce similar conformational changes in arrestin. J. Biol. Chem. 266, 18649-18654 (1991).
20. Zhan, X., Perez, A., Gimenez, L. E., Vishnivetskiy, S. A. & Gurevich, V. V. Arrestin-3 binds the MAP kinase JNK3alpha2 via multiple sites on both domains. Cell. Signal. 26, 766-776 (2014).
21. Song, X., Coffa, S., Fu, H. & Gurevich, V. V. How does arrestin assemble MAPKs into a signaling complex? J. Biol. Chem. 284, 685-695 (2009).
22. Bunce, C. M. et al. Comparison of the levels of inositol metabolites in transformed haemopoietic cells and their normal counterparts. Biochem. J. 289, 667-673 (1993). (Pt 3).
23. Sasakawa, N., Sharif, M. & Hanley, M. R. Metabolism and biological activities of inositol pentakisphosphate and inositol hexakisphosphate. Biochem. Pharmacol. 50, 137-146 (1995).
24. Milano, S. K., Kim, Y. M., Stefano, F. P., Benovic, J. L. & Brenner, C. Nonvisual arrestin oligomerization and cellular localization are regulated by inositol hexakisphosphate binding. J. Biol. Chem. 281, 9812-9823 (2006).
25. Farrens, D. L., Altenbach, C., Yang, K., Hubbell, W. L. & Khorana, H. G. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274, 768-770 (1996).
26. Scheerer, P. et al. Crystal structure of opsin in its G-protein-interacting conformation. Nature 455, 497-502 (2008).
27. Rasmussen, S. G. et al. Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 477, 549-555 (2011).
28. Szczepek, M. et al. Crystal structure of a common GPCR-binding interface for G protein and arrestin. Nat. Commun. 5, 4801 (2014).
29. Zhuang, T. et al. Involvement of distinct arrestin-1 elements in binding to different functional forms of rhodopsin. Proc. Natl Acad. Sci. USA 110, 942-947 (2013).
30. Krissinel, E. B. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774-797s (2007).
31. Zhuo, Y., Vishnivetskiy, S. A., Zhan, X., Gurevich, V. V. & Klug, C. S. Identification of receptor binding-induced conformational changes in non-visual arrestins. J. Biol. Chem. 289, 20991-21002 (2014).
32. Chen, Q. et al. Self-Association of arrestin family members. Handb. Exp. Pharmacol. 219, 205-223 (2014).
33. Gimenez, L. E. et al. Role of receptor-Attached phosphates in binding of visual and non-visual arrestins to G protein-coupled receptors. J. Biol. Chem. 287, 9028-9040 (2012).
34. Gimenez, L. E., Babilon, S., Wanka, L., Beck-Sickinger, A. G. & Gurevich, V. V. Mutations in arrestin-3 differentially affect binding to neuropeptide Y receptor subtypes. Cell Signal. 26, 1523-1531 (2014).
35. Milano, S. K., Pace, H. C., Kim, Y. M., Brenner, C. & Benovic, J. L. Scaffolding functions of arrestin-2 revealed by crystal structure and mutagenesis. Biochemistry 41, 3321-3328 (2002).
36. Luttrell, L. M. et al. Beta-Arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283, 655-661 (1999).
37. Vey, J. L. et al. Structure and mechanism of ORF36, an amino sugar oxidizing enzyme in everninomicin biosynthesis. Biochemistry 49, 9306-9317 (2010).
38. Bruender, N. A., Thoden, J. B. & Holden, H. M. X-ray structure of kijd3, a key enzyme involved in the biosynthesis of D-kijanose. Biochemistry 49, 3517-3524 (2010).
39. Vishnivetskiy, S. A., Hirsch, J. A., Velez, M. G., Gurevich, Y. V. & Gurevich, V. V. Transition of arrestin into the active receptor-binding state requires an extended interdomain hinge. J. Biol. Chem. 277, 43961-43967 (2002).
40. Hanson, S. M. et al. Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity. J. Mol. Biol. 368, 375-387 (2007).
41. Johnson, E., Nguyen, P. T., Yeates, T. O. & Rees, D. C. Inward facing conformations of the MetNI methionine ABC transporter: implications for the mechanism of transinhibition. Protein Sci. 21, 84-96 (2012).
42. Renault, L., Guibert, B. & Cherfils, J. Structural snapshots of the mechanism and inhibition of a guanine nucleotide exchange factor. Nature 426, 525-530 (2003).
43. Westblade, L. F. et al. Structural basis for the bacterial transcription-repair coupling factor/RNA polymerase interaction. Nucleic Acids Res. 38, 8357-8369 (2010).
44. Shoemaker, B. A., Portman, J. J. & Wolynes, P. G. Speeding molecular recognition by using the folding funnel: The fly-casting mechanism. Proc. Natl Acad. Sci. USA 97, 8868-8873 (2000).
45. Sugase, K., Dyson, H. J. & Wright, P. E. Mechanism of coupled folding and binding of an intrinsically disordered protein. Nature 447, 1021-1025 (2007).
46. Hanson, S. M. et al. Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin. Proc. Natl Acad. Sci. USA 103, 4900-4905 (2006).
47. Vishnivetskiy, S. A. et al. The role of arrestin alpha-helix I in receptor binding. J. Mol. Biol. 395, 42-54 (2010).
48. Laporte, S. A. et al. The beta2-Adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc. Natl Acad. Sci. USA 96, 3712-3717 (1999).
49. Kang, D. S. et al. Structure of an arrestin-2-clathrin complex reveals a novel clathrin binding domain that modulates receptor trafficking. J. Biol. Chem. 284, 29860-29872 (2009).
50. Vishnivetskiy, S. A. et al. How does arrestin respond to the phosphorylated state of rhodopsin? J. Biol. Chem. 274, 11451-11454 (1999).
51. Vishnivetskiy, S. A. et al. An additional phosphate-binding element in arrestin molecule. Implications for the mechanism of arrestin activation. J. Biol. Chem. 275, 41049-41057 (2000).
52. Kim, J. et al. Functional antagonism of different G protein-coupled receptor kinases for beta-Arrestin-mediated angiotensin II receptor signaling. Proc. Natl Acad. Sci. USA 102, 1442-1447 (2005).
53. Ren, X. R. et al. Different G protein-coupled receptor kinases govern G protein and beta-Arrestin-mediated signaling of V2 vasopressin receptor. Proc. Natl Acad. Sci. USA 102, 1448-1453 (2005).
54. Shukla, A. K. et al. Visualization of arrestin recruitment by a G-protein-coupled receptor. Nature 512, 218-222 (2014).
55. Sinha, A., Jones Brunette, A. M., Fay, J. F., Schafer, C. T. & Farrens, D. L. Rhodopsin TM6 can interact with two separate and distinct sites on arrestin: evidence for structural plasticity and multiple docking modes in arrestin-rhodopsin binding. Biochemistry 53, 3294-3307 (2014).
56. Yang, F. et al. Phospho-selective mechanisms of arrestin conformations and functions revealed by unnatural amino acid incorporation and (19)F-NMR. Nat. Commun. 6, 8202 (2015).
57. Nobles, K. N. et al. Distinct phosphorylation sites on the beta(2)-Adrenergic receptor establish a barcode that encodes differential functions of beta-Arrestin. Sci. Signal. 4, ra51 (2011).
58. Vishnivetskiy, S. A., Zhan, X., Chen, Q., Iverson, T. M. & Gurevich, V. V. Arrestin expression in E. coli and purification. Curr. Protoc. Pharmacol. 67, Unit 2 11(2014).
59. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
60. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674 (2007).
61. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004).
62. Adams, P. D. et al. PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta. Crystallogr. D Biol. Crystallogr. 66, 213-221 (2010).
63. Donoso, L. A. et al. S-Antigen: preparation and characterization of site-specific monoclonal antibodies. Curr. Eye Res. 9, 343-355 (1990).
64. Toledo Warshaviak, D., Khramtsov, V. V., Cascio, D., Altenbach, C. & Hubbell, W. L. Structure and dynamics of an imidazoline nitroxide side chain with strongly hindered internal motion in proteins. J. Magn. Reson. 232, 53-61 (2013).
65. Jeschke, G. DEER distance measurements on proteins. Annu. Rev. Phys. Chem. 63, 419-446 (2012).
66. Scheuermann, T. H., Padrick, S. B., Gardner, K. H. & Brautigam, C. A. On the acquisition and analysis of microscale thermophoresis data. Anal. Biochem. 496, 79-93 (2016).
67. Brautigam, C. A. Calculations and publication-quality illustrations for analytical ultracentrifugation data. Methods Enzymol. 562, 109-133 (2015).
68. Schuck, P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J. 78, 1606-1619 (2000).